Premium Bexagliflozin API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Premium Bexagliflozin API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Bexagliflozin (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor

Indications: Type 2 Diabetes Mellitus

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Bexagliflozin distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Bexagliflozin is a highly potent, orally active small-molecule Active Pharmaceutical Ingredient (API). In the field of endocrine and metabolic pharmacology, it is classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, widely utilized in the management of glycemic control.

The mechanism of action for this API is entirely independent of insulin secretion or action. At the physiological level, the SGLT2 transporter is located within the proximal renal tubules of the kidneys and is responsible for the majority of glucose reabsorption from the glomerular filtrate back into the systemic circulation.

By competitively binding to and inhibiting SGLT2, Bexagliflozin blocks the reabsorption of filtered glucose. This process significantly lowers the renal threshold for glucose, promoting increased urinary glucose excretion (glycosuria). For formulation scientists, integrating this API allows for the development of modern, insulin-independent anti-diabetic therapeutics. In finished pharmaceutical products, Bexagliflozin is typically formulated into 20 mg immediate-release oral solid dosage forms intended for adult patients with type 2 diabetes.

Sourcing Bexagliflozin in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced anti-diabetic formulations requires a resilient raw material pipeline. Procuring specialty APIs for local commercial manufacturing often involves navigating extended lead times, customs bottlenecks, and complex regulatory compliance. As a dedicated pharmaceutical raw material supplier, sourcing Bexagliflozin Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners that operate in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with us as your supply vendor secures several operational provisions for your facility:

• DRAP Registration Support: Morgan facilitates the transfer of all necessary regulatory documentation required for local compliance. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. This ensures your commercial batch schedules and production timelines are met without costly line stoppages.
• Batch-to-Batch Uniformity: Every delivery provided by Morgan includes a rigorously verified Certificate of Analysis (CoA) from the manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during your blending, wet granulation, and tablet compression processes.

Technical Specifications for QA & R&D

The Bexagliflozin API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: (1S)-1,5-anhydro-1-C-[4-chloro-3-(4-[2-(cyclopentyloxy)ethoxy]benzyl)phenyl]-D-glucitol
• CAS Number: 1119276-80-0
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C24H29ClO7
• Molecular Weight: 464.94 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers of varying pH levels are documented in the technical data sheet to assist your R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

While Bexagliflozin does not carry the severe teratogenic profiles of certain immunosuppressants or oncology drugs, it is a pharmacologically active compound. Facilities processing this API must enforce standard occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and humidity) to prevent degradation and moisture uptake.
• Occupational Safety: Personnel handling the pure API powder must follow standard industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and blending stages should be executed within localized exhaust ventilation systems or dedicated weighing booths to prevent inhalation of airborne particulates and cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.